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Microcephaly and congenital infections
ABSTRACT
Introduction: Microcephaly is a clinical finding that can arise from congenital anomalies 
or emerge after childbirth. Maternal infections acquired during pregnancy can result 
in characteristic brain damage in the newborn (NB), which may be visible even in 
the fetal stage. To describe the epidemiological profile of newborns with reported 
microcephaly and diagnosed with congenital infections in the state of Rio Grande do 
Sul between 2015 and 2017. 
Methods: A cross-sectional study was carried out on data collected from the Public 
Health Event Registry as well as from medical records. The investigation included 
serologies for toxoplasmosis and rubella; polymerase chain reaction (PCR) for Zika 
virus (ZIKV) in the blood and cytomegalovirus in the urine; non-treponemal tests for 
syphilis; and brain imaging tests.
Results: Of the 257 reported cases of microcephaly, 39 were diagnosed with 
congenital infections. Severe microcephaly was identified in 13 patients (33.3%) 
and 51.3% of the cases showed alterations in brain imaging tests. In relation to the 
diagnosis of congenital infections, three patients (7.7%) were diagnosed with ZIKV, 
nine (23.1%) with cytomegalovirus, nine (23.1%) with toxoplasmosis, and 18 (46.1%) 
with congenital syphilis. The three cases of ZIKV showed calcification in brain imaging 
tests, signs of arthrogryposis, excess occipital skin and irritability, characterizing the 
typical phenotype of ZIKV infection.
Conclusions: Most cases of congenital infection had severe neurological lesions, 
particularly the cases of ZIKV, which can cause neurodevelopmental delays and 
sequelae in these infants throughout early childhood.
Keywords: Microcephaly; congenital infection; zika virus
Microcephaly is a clinical finding that can arise from congenital anomalies or 
emerge after childbirth, thus having a heterogeneous diagnosis with genetical 
and environmental etiology1,2. It is defined as occipitofrontal circumference, 
or cephalic perimeter (CP), two standard deviations (SD) below the mean 
for gestational age, sex and weight, and severe microcephaly consists of CP 
less than three SD. This measure indirectly reflects the size of the brain and 
can predict anomalies in development2,3.
Among the main causes that can lead to microcephaly, congenital infections 
are included as they are important causes of neonatal morbidity and mortality. 
Maternal infections during pregnancy can result in characteristic brain damage 
in the newborn (NB), which can be visible even in the fetal stage2. In addition 
to microcephaly, these infections include hydrocephalus, brain calcification, 
ventriculomegaly, cortical migration anomalies, white matter changes and 
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cerebellar hypoplasia1, 2. The main congenital infections 
causing microcephaly and/or changes in the central 
nervous system (CNS) described in the literature are 
Zika virus (ZIKV), toxoplasmosis, syphilis, rubella 
and cytomegalovirus (CMV)1,4,5.
In February 2016, the World Health Organization 
(WHO) acknowledged the alarm issued by the 
Brazilian Ministry of Health on ZIKV infection and 
its possible association with cases of microcephaly, 
declaring a public health emergency of international 
concern. The incidence of ZIKV infection in the general 
population showed higher rates in northeastern 
Brazil6. In the state of Rio Grande do Sul, the virus 
only became endemic in April 2016, which coincided 
with the beginning of winter3. However, due to the 
epidemic that occurred in 2015-2016, microcephaly 
notification became mandatory in Brazil6. Thus, the 
objective of this study was to describe congenital 
infections in NBs with microcephaly reported from 
December 2015 to the end of 2017 in the state of 
Rio Grande do Sul.
METHODS
A cross-sectional, descriptive study was conducted 
with samples collected from 257 NBs with microcephaly 
reported to the Public Health Event Registry (RESP) in 
the state of Rio Grande do Sul between December 1, 
2015 and December 31, 2017.
The criteria for RESP reporting, in the first three 
months of the study, were defined as CP at birth 
(measured between 24 hours up to 7 days of life) less 
than 32 centimeters for all NBs7. After that, microcephaly 
was defined for 2 months as CP at birth less than 
31,9 cm in boys and 31,5 cm in girls, or less than 
two SD, considering sex and gestational age, using 
WHO graphs for term infants and Fenton graphs for 
preterm infants8. After the Ministry of Health reviewed 
the criteria, microcephaly was redefined as CP lower 
than two SD in relation to the mean for gestational age 
and gender8, using the InterGrowth spreadsheets for 
premature NBs and WHO tables for full-term, normal 
delivery NBs, corrected for sex and gestational age9. 
Data on birth, CP, weight, gestational age, clinical 
and radiological changes, maternal and gestational 
conditions, and pregnant women’s possible exposures 
were collected from RESP records.
Case evaluation flow: The evaluation of the cases 
reported to RESP started at the State Health Surveillance 
Center (CEVS), which centralized the information of 
the reported cases sent by health services from each 
municipality. A multidisciplinary team of geneticists, 
pediatricians, neurologists and nurses evaluated all 
RESP records and Rio Grande do Sul Central Laboratory 
(LACEN) results. Patient care and evaluation were 
initially performed in the city of origin and, if the local 
facility did not provide the necessary professionals and 
tests for the investigation, patients were then referred 
to Hospital de Clínicas in Porto Alegre, capital of Rio 
Grande do Sul. For these patients, additional tests were 
performed, including imaging and other specific tests as 
indicated for each case. The NB investigation at Hospital 
de Clínicas included clinical evaluation, information on 
gestation, and brain imaging for diagnosis or exclusion 
of infectious disease.
Diagnostic criteria and laboratory analyses: 
In order to establish the diagnosis of congenital 
infection, NB’s clinical manifestations as well as 
NB’s and mother’s test results were considered. 
Simultaneously to the notification, blood samples 
from the mother and NB were sent to LACEN, where 
serologies (direct chemiluminescence) were performed 
for toxoplasmosis and rubella, and polymerase chain 
reaction (PCR) was performed for ZIKV in the blood. 
Venereal Disease Research Laboratory (VDRL) 
test in the blood for syphilis and PCR in the urine or 
cerebrospinal fluid (CSF) for CMV were collected in 
the laboratory. Tests for herpes virus could not be 
carried out because they are currently unavailable 
in the public health system.
Brain imaging tests consisted of ultrasonography 
(US), computed tomography (CT) or magnetic resonance 
imaging (MRI), in order to evaluate anomalies in the 
CNS in the NBs.
For diagnostic specificity, the following criteria 
were used: 1) congenital ZIKV infection confirmed 
through the mother’s travel history to epidemic/
endemic regions in 2015 (see below), skin rash with 
or without pruritus, joint pain and fever, typical CNS 
imaging and clinical examination of the NB, or PCR 
test for ZIKV in the mother’s and the NB’s blood10; 2) 
congenital CMV infection confirmed by positive PCR 
in the urine; 3) toxoplasmosis and rubella confirmed 
by serology with positive immunoglobulin (IgM) in 
the blood; 4) congenital syphilis confirmed by the 
VDRL test in the NB’s blood and/or CSF or positive 
fluorescent treponemal antibody absorption (FTA-
ABS) test in the NB.
Definition of epidemic/endemic region: For NBs 
whose mothers were pregnant in 2015, history of 
travel or residence was checked as well as any 
available information on detection of autochthonous 
or imported cases of ZIKV infection. As of 2016, 
ZIKV was known to circulate in Rio Grande do Sul; 
therefore, history of travel was not considered part 
of criteria for diagnosis or suspicion10. 
Statistical analysis: Data analysis was performed 
using the Statistical Package for Social Sciences 
(SPPS®), version 20.0. Descriptive data were shown 
as frequency, while parametric variables were shown 
as mean ± standard deviation.
Ethical aspects: The project was submitted to the 
Human Research Ethics Committee of the Hospital 
de Clínicas Research and Graduate Studies Group 
(GPPG/HCPA 169577). It is in compliance with the 
regulations in force in the scope of research involving 
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human beings, in particular National Health Council 
Resolution no. 466 of 2012 and complementary 
resolutions, in addition to the rules and regulations of 
the institution.
RESULTS
Of the 257 infants with microcephaly reported in this 
period, 39 were diagnosed with congenital infections. 
The general sample description is shown in Table 1. 
In relation to the diagnosis of congenital infections, 
three patients (7.7%) were diagnosed with ZIKV 
(Table 2), nine (23.1%) with congenital CMV (Table 3), 
nine (23.1%) with congenital toxoplasmosis (Table 4), 
and 18 (46.1%) with congenital syphilis (Table 5). 
No cases of congenital rubella were diagnosed, and 
mothers showed immunity to this disease in 91.6% 
of all cases reported.
Table 1: Characteristics of the mothers and their 39 newborns with microcephaly and/or central nervous system changes 
diagnosed with congenital infection.










Very low weight (< 1,500 grams) 5 12.8
Low weight (1,500-2,500 grams) 19 48.7
Normal weight (> 2,500 grams) 15 38.5
Small for gestational age 16 41.0
Zika virus (n = 3) 2 66.7
Cytomegalovirus (n = 9) 2 22.2
Toxoplasmosis (n = 9) 4 44.4
Syphilis (n = 18) 8 44.4
Prematurity 13 33.3
Zika virus (n = 3) 0 0
Cytomegalovirus (n = 9) 3 33.3
Toxoplasmosis (n = 9) 4 44.4
Syphilis (n = 18) 6 33.3
Severe microcephaly (CP < 3 SD) 13 33.3
Zika virus (n = 3) 2 66.7
Cytomegalovirus (n = 9) 3 33.3
Toxoplasmosis (n = 9) 2 22.2
Syphilis (n = 18) 6 33.3
Cerebral alterations in imaging tests* 20 51.3
Zika virus (n = 3) 3 100
Cytomegalovirus s (n = 9) 6 66.7
Toxoplasmosis (n = 9) 7 77.8
Syphilis (n = 18) 4 22.2
Continue...
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Maternal characteristics N (%)
Age
< 20 7 17.9
20-35 28 71.8





*Brain imaging test was carried out in 31 patients. CP: cephalic perimeter; SD: standard deviation.
Table 2: Description of cases of congenital Zika virus syndrome (n = 3).
No. Sex GA WB CP/Percentile 
PCR
Altered Brain Imaging Test
1 M 37 2,740 31< 2 SD ND
CT: Small punctate periventricular calcifications 
together with increased dimensions of the 
ventricular system with predominance of the 
posterior horns (colpocephaly) and irregularity in 
the contours. 
MRI: Lissencephaly and polymicrogyria. 
Pachygyria. Reduction of supratentorial white 
matter. Craniofacial disproportion.
2 F 38 2,436 27< 3 SD ND
MRI: Brain atrophy. Lissencephaly, pachygyria, 
microcalcifications. 
3 F 37 2,100 26.5< 3 SD ND
MRI: Craniofacial disproportion. Brain atrophy, 
lissencephaly, calcifications. 
No: number of identification; WB: weight at birth in grams; GA: gestational age in weeks; CP: cephalic perimeter in centimeters; SD: 
standard deviation; PCR: polymerase chain reaction; ND: non-detectable; CT: computed tomography; US: ultrasonography; MRI: 
magnetic resonance imaging.
Table 3: Description of cases of congenital cytomegalovirus syndrome (n=9).
No. Sex GA WB CP/Percentile 
PCR
Altered Brain Imaging Test
4 F 38 2,490 30< 3 SD
Urine
CSF
US: Cystic images in bilateral subependymal situation. 
CT with no alterations.
5 F 35 2,320 30<2 SD Urine
US: Areas of periventricular calcification, reduced 
volumes in the frontal and parietal gyri. Corpus 
callosum formed, but thin. 
CT: Small bilateral periventricular calcifications.
MRI: Periventricular calcifications. 
6 M 37 2,685 31< 2 SD Urine CT with no alterations.
7 M 37 2,510 29< 3 SD Urine
MRI: Overall increase in CSF spaces by encephalic 
volume reduction. Cortical gyri and sulci simplification, 
with areas of cortical thickening related to a neuronal 
migration disorder with a predominant pattern of 
polymicrogyria.
Periventricular calcifications. Alteration in cerebellum 
morphology.
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Table 3: Continuation
No. Sex GA WB CP/Percentile 
PCR
Altered Brain Imaging Test
9 M 40 2,255 28.5< 3 SD Urine
CT: Signs of reduced cranial volume. Bilateral front 
parietal parenchymal calcifications of less than 6 mm. 
Lateral ventricles grossly parallel, which might be 
related to colpocephaly.
10 F 39 3,355 34.5Adequate Urine
MRI: Craniofacial disproportion. Enlargement of 
lateral ventricles and third ventricle. Corpus callosum 
splenium not identified, callosal dysgenesis. 
Prominence of CSF spaces in frontal regions.
11 M 35 2,362 29< 2 SD Urine
US: Ventricular dilation. Supratentorial hydrocephalus. 
Reduced parenchymal thickness. Multiple calcified foci. 
12 M 36 2,795 30.5<1 SD Urine Imaging test not performed.
No: number of identification; WB: weight at birth in grams; GA: gestational age in weeks; CP: cephalic perimeter in centimeters; SD: standard 
deviation; PCR: polymerase chain reaction; CSF: cerebrospinal fluid; CT: computed tomography; MRI: magnetic resonance imaging; US: 
ultrasonography.
Table 4: Description of cases of congenital toxoplasmosis (n=9).
No. Sex GA WB CP/Percentile IgM
Ophthalmologic 
Alteration Brain Imaging Test
13 F 37 2,405 31.5< 2 SD CSF Normal fundus
US: Tiny hypo/anechoic image in the 
choroid plexus of left lateral ventricle 
(small cyst).




US: Calcifications, cysts, parenchymal 
reduction, accentuated hydrocephalus, 
leukoencephalomalacia. 
CT: Hydrocephalus, calcifications.
15 F 38 2,668 31< 2 SD Blood Normal fundus CT with no alterations.
16 F 39 2,830 31.5 < 2 SD Blood NP CT with no alterations.
17 M 38 2,625 30<3 SD
Blood/
CSF NP
CT: Diffuse cortical sulci prominence. 
Apparent callosal dysgenesis. 
Hypoplasia of the cerebellum.
18 F 31 1,200 24.5 < 2 SD
Blood/
CSF
Posterior uveitis with 
macular involvement 
and vitreitis
CT: Gross calcifications predominantly 
bilateral and symmetrical cortical 
and next to walls of lateral ventricles. 
Ventricular system dilation, 
colpocephaly. 
19 F 38 2,570 30.5 < 2 SD CSF Normal fundus
CT: Small subdural collection next to 
territory and occipital region. Small right 
parietal brain hematoma.
20 F 1,070 24 < 3 SD Blood NP
US: Minimum increase in echogenicity 
of periventricular white matter.
CT: Signs of reduced cranial volume.
21 F 2,430 30.5< 1 SD Blood NP
US: Small calcifications. 
Encephalomalacia. Ventriculomegaly.
No: number of identification; WB: weight at birth in grams; GA: gestational age in weeks; CP: cephalic perimeter in centimeters; SD: standard 
deviation ; IgM: immunoglobulin M ; CSF: cerebrospinal fluid; CT: computed tomography; US: ultrasonography; NP: not performed.
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Table 5: Description of cases of congenital syphilis (n = 18).




NB Brain Imaging Test
22 M 33 1,455 27.2< 2 SD 1:256 1:64 US: Grade 1 hemorrhage.
23 F 38 2,310 30< 3 SD 1:8 1:2 NA
 24 F 38 3,160 31< 2 SD 1:8 FTA-ABS R US with no alterations.
25 F 38 2,500 30.5< 2 SD 1:4
1:1
FTA-ABS R NA
26 F 37 2,535 30< 3 SD 1:8 R* NA
27 F 37 2,740 31.5< 2 SD 1:1  R* CT with no alterations.
28 F 37 1,725 30< 3 SD 1:4 1:1 US with no alterations. 
29 F 32 1,120 26< 2 SD 1:2 R*
US: Mineralizing vasculopathy in 
thalamus. Ventricles of normal 
dimensions and aspects.
30 F 35 1,535 27< 3 SD 1:64 1:8 US with no alterations.
31 M 37 1,785 30< 3 SD 1:8 1:1
US: Suggestive of congenital infections. 
Cystic images in the caudothalamic 
groove.
32 F 38 2,775 31.5< 2 SD 1:4 1:4 NA
33 F 35 2,015 30< 1 SD 1:1024 FTA-ABS R US with no alterations.
34 F 41 3,105 31< 2 SD 1:2 FTA-ABS R US with no alterations.
35 F 36 1,995 29< 2 SD 1:64 1:16 US with no alterations.
36 F 37 2,195 30.5< 1 SD 1:32 1:16 NA
37 F 31 1,125 25< 2 SD 1:64 1:16 NA
38 M 38 2,040 31< 2 SD 1:16 1:4 NA
39 M 38 2,085 29.5< 3 SD 1:32 1:16
US: Suggestive of congenital infections. 
Vasculopathy of thalamus.
No: number of identification; WB: weight at birth in grams; GA: gestational age in weeks; CP: cephalic perimeter in centimeters; R: reagent (but 
with no titration values available); SD: standard deviation; NA: not available; CT: computed tomography; US: ultrasonography; VDRL: Venereal 
Disease Research Laboratory; FTA-ABS: fluorescent treponemal antibody absorption test.
 ZIKV embryopathy
Patient 1 – the mother presented with red spots 
and reported having traveled to southeast Brazil 
(where ZIKV was circulating) about ten days before 
symptom onset, at the end of the first gestational 
trimester. The NB exhibited developmental dysplasia, 
bilateral feet malposition, and strabismus.
Patient 2 – the mother presented with red spots, 
fever, myalgia, arthralgia and retro-orbital pain at 
the end of the first gestational trimester, about ten 
days after traveling to northeast Brazil, where the 
virus was circulating.
Patient 3 – the mother reported not having traveled 
during pregnancy but showed typical symptoms of 
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ZIKV infection, such as exanthema, arthralgia and 
myalgia, in the second gestational trimester. This NB 
presented overriding sutures, increased prominence 
of supraorbital ridge, retrognathia, delayed tooth 
eruption, arthrogryposis, motor hypoactivity, hypertonia, 
cortical thumb and neuropsychomotor development 
delay (NPMD).
All mothers and their NBs had negative PCR 
for ZIKV in the postnatal period. This test was not 
available at the time of clinical symptoms in the 
pregnant women. All NBs demonstrated phenotypic 
findings compatible with ZIKV embryopathy, including 
arthrogryposis, increased skin fold in the occipital 
region, and alterations in neurological examination 
(irritability, excessive crying, hypertonia, excessive 
thumb adduction, hyperactive myotatic reflexes).
Congenital CMV
Among the nine patients diagnosed with congenital 
CMV, five presented with severe microcephaly. Of 
eight NBs who underwent imaging tests, six presented 
with cerebral anomalies compatible with congenital 
infections. Three NBs underwent ophthalmologic 
evaluation; NB 5 presented with nonspecific alterations 
in the retina and NB 6 presented with microphthalmia.
Congenital toxoplasmosis
Among the nine NBs diagnosed with congenital 
toxoplasmosis, two presented with severe microcephaly. 
All nine NBs underwent imaging tests, and seven 
had alterations. NBs 14, 18 and 21 presented with 
brain calcifications and NB 14 also presented with 
hydrocephalus. Five NBs underwent ophthalmologic 
evaluation, and three presented with severe changes 
compatible with toxoplasmosis.
Congenital syphilis
Among the eleven NBs who underwent imaging 
tests, four had cerebral alterations. The maternal 
VDRL titration ranged from 1:4 to 1:250, while the NB 
VDRL titration ranged from 1:1 to 1:64. The VDRL in 
the CSF was collected from eight NBs, two of which 
were altered. Six NBs underwent long bone x-ray, 
all without alterations.
DISCUSSION
As the ZIKV epidemic began in Brazil at the end 
of 2015, the Brazilian Ministry of Health adopted 
the compulsory surveillance of microcephaly cases 
and CNS alterations in order to establish causality 
between such alterations and ZIKV infection6. This 
made it possible to know not only the prevalence at 
birth of a previously neglected condition but also other 
causes of microcephaly due to infections occurring 
earlier than 2015 in the state of Rio Grande do Sul and 
the rest of Brazil. These infections already had their 
profile of gestational outcomes known; however, the 
impact they had on the population was unknown. In 
Brazil, the Ministry of Health includes prenatal testing 
and treatments for toxoplasmosis and syphilis11. In 
the past decade, the Ministry of Health improved the 
assistance of pregnant women through protocols, 
thus reducing perinatal and neonatal morbidity 
and mortality. A great example is the eradication of 
congenital rubella in 2010 through vaccination in 
women of childbearing age, confirmed by the fact that 
no NBs were diagnosed with such infection. Moreover, 
the mothers of the reported NBs showed 91.6% of 
acquired immunity to rubella, which is consistent with 
the worldwide goal of rubella infection eradication 
achieved by Brazil’s vaccination program12.
In this study, 48.7% of the NBs were small for 
gestational age and 33.3% were preterm. Such 
characteristics are commonly found in congenital 
infections due to the activation of the inflammatory 
response in these babies1. Similar data of low 
weight and prematurity were related to patients 
with microcephaly13,14. In addition, low birth weight 
and prematurity are factors that increase the risk of 
perinatal mortality and future sequelae, as damage to 
the fetus is irreversible. Early diagnosis and treatment 
for pregnant women and NBs can minimize sequelae, 
especially in cases of toxoplasmosis and syphilis2.
An important finding in the sample evaluated was 
the fact that 33.3% of the NBs had severe microcephaly 
and 51.3% presented with alterations in the imaging 
tests, indicating a high rate of severe neurological 
abnormalities and reinforcing the knowledge of how 
important these infections can be when compromising 
the NB. In this study, three cases of ZIKV were 
identified, which corresponds to a very small number 
when compared to the rest of Brazil. The distribution 
of infection by the virus in Brazil was mostly (70.4%) 
in the Northeast region, whereas the South region 
was less affected due to local climate6. Rio Grande do 
Sul is the southernmost state in Brazil and, in winter, 
average temperatures range from 15 ºC to 18 ºC. 
In April 2016, when the number of cases began to 
increase, temperature was already declining, which 
did not favor the spread of the disease by its main 
vector, the Aedes aegypti mosquito8.
The clinical presentation of ZIKV embryopathy 
cases, including arthrogryposis, increased skin fold 
in the occipital region, alterations in neurological 
and imaging tests compatible with the classic clinical 
picture of ZIKV infection (brain calcification and 
delayed brain development) as described in the 
literature, was crucial for diagnosis15,16.
Cases of microcephaly associated with ZIKV 
accounted for 5% of all cases of microcephaly 
evaluated between 2015 and 2017. In 2016, there 
were three confirmed cases. In 2017, there were 
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one confirmed case and five probable cases. 
The study was performed during the period of highest 
prevalence of ZIKV infection in Brazil. In recent years, 
cases dropped significantly17. 
The CMV cases had important alterations in the 
brain imaging tests as well as several cases of severe 
microcephaly, in contrast to the existing literature, 
which reports only 20% to 30% of patients with 
severe symptoms and brain alterations18. Although 
congenital infection is more frequent due to high 
seropositivity rates in developing countries, about 
90% of the infected are born asymptomatic and, of 
these, 5% to 15% may develop neurological and 
sensorineural symptoms in the first months or years 
of life. Among those who are symptomatic at birth, 
the percentage of sequelae is much higher (greater 
than 50% to 80%)19. Early diagnosis of congenital 
CMV infection and clinical follow-up are essential 
for detecting and handling the disease, especially 
to prevent sequelae. Despite the importance of this 
infection, many infants congenitally infected with 
CMV remain unidentified because screening is not 
routinely carried out in prenatal care and more than 
90% of the affected babies are asymptomatic at birth11. 
Among the NBs with congenital toxoplasmosis, 
only one case of hydrocephalus, three cases of 
chorioretinitis, and three cases of brain calcification 
were identified. Similar results were found in a previous 
study with a similar population, which identified 
microcephaly in 20.8%, intracranial calcification in 
37.5% and chorioretinitis in 54% of the sample20. 
Screening for toxoplasmosis during pregnancy can 
anticipate the diagnosis so that treatment is performed 
at gestation, reducing the risk of injury to the NB11, 21.
Syphilis was the most frequent congenital infection 
in the study (46.1%), as expected. The rate of 
transmission from the pregnant woman to the fetus 
was 70% to 100% depending on the stage of the 
disease, significantly higher than other infections2. 
Despite the Ministry of Health’s efforts to reduce 
syphilis, this disease is still associated with other 
risk factors, such as human immunodeficiency 
virus (HIV) infection and drug use22. The difficulties 
in reducing the incidence and transmission of this 
disease may be partially explained by a generally 
asymptomatic condition and inadequate treatment of 
the pregnant woman and the partner11,23. In addition, 
the 2016 Epidemiological Bulletin of the Ministry of 
Health warned of the growing number of cases of 
syphilis in the country in recent years, especially 
in the South region, emphasizing that Porto Alegre 
has a congenital syphilis rate four times higher than 
the national average. This increase in recent years 
is consistent with our findings of a large number of 
cases of congenital syphilis and microcephaly24.
This study has some limitations associated with the 
use of retrospective data susceptible to information 
bias. In addition, the gestational period in which 
most infections occurred could not be established, 
to compare with the clinical findings of the NB. 
The study was developed during a period of 
modification of Ministry of Health guidelines regarding 
the diagnostic criteria of microcephaly, and health 
professionals needed to identify a disease that was 
not well known yet. Since the availability of the tests 
needed to be absorbed by health services, brain 
imaging tests such as MRI became costly and more 
difficult to access. However, in this study, US and 
CT tests showed specific alterations of infectious 
diseases with adequate precision.
After the onset of mandatory reporting of NBs 
with microcephaly and/or other CNS changes, it 
was possible to describe these conditions and their 
association with microcephaly and other neurological 
changes. Actions that already exist can be improved, 
particularly for preventable causes. Prevention of 
ZIKV infection has been the focus of efforts taken by 
the Ministry of Health, including vector control and 
guidelines for women who wish to become pregnant.
This study shows the importance of mandatory 
reporting as a measure to identify the frequency that 
microcephaly is caused by congenital infections, 
including ZIKV. Infection with this virus was infrequent 
in the study, which was expected due to the low 
circulation of the virus in our state. Most cases of 
congenital infections include severe neurological 
lesions, especially the cases of ZIKV infection, which is 
known to cause neurological development delays and 
sequelae to infants during early childhood. Thus, this 
study can serve as a basis for public health policies 
on how to handle these infections in pregnancy and 
on the care and health needs of the NB.
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